MISSION
At Melior Capital Management we specialise in providing funding to medtech, biotech or pharmaceutical companies by applying institutional quality service and process to provide capital.
VISION
Melior was launched by an experienced group of individuals who understood that there was a real opportunity for a stirringly new approach to financing within the life-science sector by building a renowned world class team of experts from the sector.
EXPERIENCE
Our distinctive approach, combined with the global reputation of our scientific, management and advisory team, enables us to select preeminent investment opportunities with credible returns.
ACHIEVEMENTS
Our team has a proven, publicly verifiable, track record of having taken over sixty drugs and medtech projects to market during their careers, including a number of multi-billion dollar blockbusters.
About
Melior Capital Management is a Swiss domiciled company investor and advisory firm focused exclusively on the global life-science sector.
We specialise in providing funding to medtech, biotech and pharmaceutical companies by applying institutional quality service and process to provide capital.
Our investment approach is to fund qualified innovative projects, with proven management teams, promising data, robust IP, strong corporate governance and a likely opportunity for significant commercial upside in the short to the medium term.
History
Our team is the bedrock of our success.
Melior was founded by an experienced group of individuals who understood that there was a real opportunity for a stirringly new approach to financing within the life-science sector by building a renowned world class team of experts from the sector, minimising commercial risks and mitigating operational risks with the highest levels of due diligence and by aligning the interests of all parties, including the investee, investor and professional intermediaries.
Our Approach
At Melior we are committed to applying best practice in corporate governance and investor transparency. We invest time and money on IP, commercial and scientific due diligence, provide unparalleled access to a world-renowned team and have a proven track record of delivering at the highest levels.
Our due diligence and review process seeks to identify investee candidates with compelling research and data, a strong existing management team who are willing and determined to build a scalable international business.
Melior is proud to be working with regulated intermediaries, such as wealth managers, private banks, single & multi-family offices and other professional advisers who represent both private and institutional investors in Europe, North America and the Middle East.
